Active Ingredient(s): Rituximab-arrx
FDA Approved: * December 17, 2020
Pharm Company: * AMGEN INC
Category: Cancer

Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer.[9] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in non-geriatric patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers.[9][10&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Riabni 100 mg/10ml Intravenous Injection, Solution
NDC: 55513-224
Amgen Inc
Riabni 500 mg/50ml Intravenous Injection, Solution
NDC: 55513-326
Amgen Inc

Related Brands

Drugs with the same active ingredients